Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Anthrax may be the next tool in the fight against bladder cancer

Anthrax may soon help more people win the fight against bladder cancer, which the Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000, and is one of the most expensive cancers to treat.

The current treatments for bladder cancer are invasive for patients - who often must sit for hours at a time with a bladder full of an agent designed to kill cancer cells and tumours.

Bladder cancer also is one of the most reoccurring for people diagnosed with the disease.

Now, researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumours.

The research is published in the Oct. 4 edition of the International Journal of Cancer.

"We have effectively come up with a promising method to kill the cancer cells without harming the normal cells in the bladder," said R. Claudio Aguilar, an associate professor and the assistant head of biological sciences in Purdue's College of Science.

"It is basically like creating a special solution that targets cancer cells while leaving healthy cells alone."

Aguilar said the bladder has its own protective layer, which saves the good cells from the anthrax mixture but offers no protection for the cancer cells and tumours.

He said the Purdue system works within minutes - instead of the usual hours for bladder cancer treatment - to target the cancer cells in the bladder.

"We have seen outstanding results with our treatment," said Aguilar, who works as part of a team focused on cell identity and signalling at the Purdue University Center for Cancer Research.

"It is fast and effective, both of which are critical for people dealing with this devastating disease."

Aguilar and his group worked with the Purdue teams led by Timothy Ratliff and Deborah Knapp to test their solution in dogs with bladder cancer who had run out of other treatment options.

They found this new agent decreased the tumour size without causing any other side effects in the animals.

The Purdue team thinks a similar treatment may help people and animals with other cancers, including those affecting the lungs or skin.

Source: Purdue University

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation